255 related articles for article (PubMed ID: 32305129)
1. Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model.
McAdoo SP; Prendecki M; Tanna A; Bhatt T; Bhangal G; McDaid J; Masuda ES; Cook HT; Tam FWK; Pusey CD
Kidney Int; 2020 Jun; 97(6):1196-1207. PubMed ID: 32305129
[TBL] [Abstract][Full Text] [Related]
2. Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Prendecki M; Gulati K; Pisacano N; Pinheiro D; Bhatt T; Mawhin MA; Toulza F; Masuda ES; Cowburn A; Lodge KM; Tam FWK; Roufosse C; Pusey CD; McAdoo SP
Arthritis Rheumatol; 2023 Jan; 75(1):84-97. PubMed ID: 36428281
[TBL] [Abstract][Full Text] [Related]
3. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis.
Prendecki M; Gulati K; Turner-Stokes T; Bhangal G; Chiappo D; Woollard K; Cook HT; Tam FW; Roufosse C; Pusey CD; McAdoo SP
J Pathol; 2021 Oct; 255(2):107-119. PubMed ID: 34124781
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
7. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
8. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
9. C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis.
Korsten P; Baier E; Hakroush S; Tampe B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834488
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?
McAdoo SP; Pusey CD
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i80-i88. PubMed ID: 28391344
[TBL] [Abstract][Full Text] [Related]
11. Regulation of NETosis and Inflammation by Cyclophilin D in Myeloperoxidase-Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Kudo T; Nakazawa D; Watanabe-Kusunoki K; Kanda M; Shiratori-Aso S; Abe N; Nishio S; Koga JI; Iwasaki S; Tsuji T; Fukasawa Y; Yamasaki M; Watanabe M; Masuda S; Tomaru U; Murakami M; Aratani Y; Ishizu A; Atsumi T
Arthritis Rheumatol; 2023 Jan; 75(1):71-83. PubMed ID: 35905194
[TBL] [Abstract][Full Text] [Related]
12. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
13. Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fcgamma receptors and CD18.
Hewins P; Williams JM; Wakelam MJ; Savage CO
J Am Soc Nephrol; 2004 Mar; 15(3):796-808. PubMed ID: 14978183
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of ANCA-associated vasculitides.
Kallenberg CG
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
[TBL] [Abstract][Full Text] [Related]
15. [Pathology of the ANCA-associated vasculitides].
Ferrario F; Vanzati A; Pilla D; Pagni F
G Ital Nefrol; 2013; 30(2):. PubMed ID: 23832458
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis?
van Paassen P; Tervaert JW; Heeringa P
Nephron Exp Nephrol; 2007; 105(1):e10-6. PubMed ID: 17108705
[TBL] [Abstract][Full Text] [Related]
18. Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis.
Dooley D; van Timmeren MM; O'Reilly VP; Brady G; O'Brien EC; Fazekas B; Hickey FB; Leacy E; Pusey CD; Tam FWK; Mehrling T; Heeringa P; Little MA
Kidney Int; 2018 Nov; 94(5):926-936. PubMed ID: 30158055
[TBL] [Abstract][Full Text] [Related]
19. An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade.
Hayes MJ; Cambridge G
Mol Immunol; 2004 Jun; 41(4):457-68. PubMed ID: 15163542
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
